Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/16/2010CA2778931A1 Guanine riboswitch binding compounds and their use as antibiotics
12/16/2010CA2774883A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010CA2772869A1 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
12/16/2010CA2765330A1 Reduction of opioid blood fluctuations
12/16/2010CA2765329A1 Oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders
12/16/2010CA2765291A1 Sublingual apomorphine
12/16/2010CA2765181A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010CA2765172A1 Novel pharmaceutical compositions containing pregabalin
12/16/2010CA2765171A1 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
12/16/2010CA2765150A1 2, 3-dihydro-1h-indene compounds and their use to treat cancer
12/16/2010CA2765129A1 Chemical modification motifs for mirna inhibitors and mimetics
12/16/2010CA2765114A1 Hedgehog pathway antagonists and therapeutic applications thereof
12/16/2010CA2765086A1 Iminosugars and methods of treating bunyaviral and togaviral diseases
12/16/2010CA2765075A1 Egfr and par2 regulation of intestinal permeability
12/16/2010CA2765053A1 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
12/16/2010CA2765050A1 Ureidophenyl substituted triazine derivatives and their therapeutical applications
12/16/2010CA2765047A1 Pyridyl-triazine inhibitors of hedgehog signaling
12/16/2010CA2765044A1 Benzyl substituted triazine derivatives and their therapeutical applications
12/16/2010CA2765033A1 Methods for treating gastrointestinal disorders
12/16/2010CA2765030A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764989A1 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010CA2764983A1 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
12/16/2010CA2764981A1 (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamoylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors
12/16/2010CA2764980A1 Styryl-triazine derivatives and their therapeutical applications
12/16/2010CA2764885A1 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak
12/16/2010CA2764867A1 Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
12/16/2010CA2764823A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764822A1 New potent anti apob antisense compounds
12/16/2010CA2764818A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764809A1 Otic foam formulations
12/16/2010CA2764808A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
12/16/2010CA2764807A1 Methods and compositions for the induction of hypothermia
12/16/2010CA2764785A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764782A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
12/16/2010CA2764728A1 Janus kinase inhibitor compounds and methods
12/16/2010CA2764694A1 Pyridinyl derivatives asinhibitors of enzyme nicotinamide phosphoribosyltransferase
12/16/2010CA2764653A1 Tetracyclic compounds
12/16/2010CA2764646A1 Therapeutic agent and assay
12/16/2010CA2764622A1 Substituted benzimidazoles, benzothiazoles and benzoxazoles
12/16/2010CA2764600A1 Crystalline forms of febuxostat
12/16/2010CA2764587A1 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
12/16/2010CA2764567A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010CA2764481A1 Pharmaceutical composition for use in medical and veterinary ophthalmology
12/16/2010CA2764472A1 Aptamer for chymase, and use thereof
12/16/2010CA2764430A1 Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof
12/16/2010CA2764376A1 High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
12/16/2010CA2764252A1 Substituted 16,17-annellated steroid compounds for use in women's healthcare
12/16/2010CA2764172A1 A thrombin receptor antagonist and clopidogrel fixed dose tablet
12/16/2010CA2764141A1 Heterocyclic antiviral compounds
12/16/2010CA2764027A1 Compounds useful for treating premature aging and in particular progeria
12/16/2010CA2764026A1 Compounds useful for treating aids
12/16/2010CA2764024A1 Compounds useful for treating cancer
12/16/2010CA2763931A1 Use of substituted oxindole derivatives for the treatment and prophylaxis of pain
12/16/2010CA2763923A1 Semi-solid compositions and pharmaceutical products
12/16/2010CA2763862A1 Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms
12/16/2010CA2763837A1 Solid compositions comprising 5-aminolevulinic acid
12/16/2010CA2763786A1 Alkanoylamino benzamide aniline hdac inihibitor compounds
12/16/2010CA2763717A1 Pyrimidine derivatives as zap-70 inhibitors
12/16/2010CA2763683A1 Pyrazole oxadiazole derivatives as s1p1 agonists
12/16/2010CA2763537A1 Methods for treating chronic kidney disease
12/16/2010CA2763441A1 Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor
12/16/2010CA2763167A1 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
12/16/2010CA2763092A1 Use of a composition for the treatment of mucositis
12/16/2010CA2762916A1 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
12/16/2010CA2762890A1 Neuroprotective properties of 5'-methylthioadenosine
12/16/2010CA2762619A1 Novel cyclopentane derivatives
12/16/2010CA2760887A1 Oxazole and thiazole derivatives as alx receptor agonists
12/16/2010CA2760588A1 Fluorinated aminotriazole derivatives
12/16/2010CA2737601A1 Anti-viral compounds
12/15/2010EP2261665A2 Methods of diagnosing and treating Crohn's disease
12/15/2010EP2261664A2 Methods of treating bloating, abdominal pain and diarrhea
12/15/2010EP2261337A1 DNA sequence and recombinant production of group 4 major allergens from cereals
12/15/2010EP2261336A1 DNA sequence and recombinant production of group 4 major allergens from cereals
12/15/2010EP2261335A1 Compositions and methods for increasing bone mineralisation
12/15/2010EP2261334A2 Modified polynucleotides for use in RNA interference
12/15/2010EP2261333A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
12/15/2010EP2261263A1 Processed starch powder with excellent disintegration properties and manufacturing method thereof
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2261226A1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/15/2010EP2261225A1 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/15/2010EP2261224A2 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors
12/15/2010EP2261223A1 Pyrimidine derivatives used as pi-3 kinase inhibitors
12/15/2010EP2261221A1 Epothilone analogues, their pharmaceutical compositions, their use and their preparations
12/15/2010EP2261218A2 Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
12/15/2010EP2261216A2 Pyrazoles as glucokinase activators
12/15/2010EP2261214A1 Compounds useful to treat premature aging and in particular progeria
12/15/2010EP2261213A1 Heterocyclic compound
12/15/2010EP2261211A1 1,4-dihydropyridine derivatives and their uses
12/15/2010EP2261210A1 3-substituted sulfonyl piperazine derivative
12/15/2010EP2261209A1 Novel crystalline forms of 4-[4-[4- hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenene acetic acid and its hydrochloride
12/15/2010EP2261208A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010EP2261207A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010EP2261206A1 Indolinone compound
12/15/2010EP2261203A1 Phenylcyclobutylamide derivatives and their stereoisomers, the preparing processes and the uses thereof
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260903A1 C-19 steroids for therapeutic uses
12/15/2010EP2260870A2 Treatment of infectious diseases with combinations of a thioxanthene derivative with an anti-infective agent
1 ... 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 ... 7860